EUVIMEDDescubrir EUVIMED
Crossref

Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs ( Sus scrofa domestica )

Stephanie Kleine iD, Chiara E Hampton, Christopher Smith, Genevieve Bussieres, Pierre-Yves Mulon, Reza Seddighi, Sherry Cox, Joe Smith

Journal of Veterinary Pharmacology and Therapeutics · 2023

DOI: 10.1111/jvp.13402 ↗

At a glance

Journal article in Journal of Veterinary Pharmacology and Therapeutics, 2023. Written by Stephanie Kleine and 7 co-authors. Institution: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA. Major MEDLINE topics: Osteoarthritis, Dog Diseases, Swine Diseases. Cited 2 times so far (Crossref); 30 references. Funded by: University of Tennessee, Knoxville.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Both pet and research pigs can suffer from some degree of pain from surgery, injuries, or osteoarthritis (OA). Despite this, there is a paucity of data on safe and effective analgesia agents in pigs. Grapiprant is an EP4 antagonist that blocks the action of the pro‐inflammatory prostanoid, PGE 2 . It has shown efficacy in attenuating pain associated with ovariohysterectomy and OA in dogs. However, there are no data regarding grapiprant in pigs. Therefore, the pharmacokinetic profile of orally administered grapiprant to juvenile pigs ( Sus scrofa domestica ) was evaluated in this study. Seven juvenile pigs received 12 mg/kg grapiprant orally. Blood was collected from an indwelling jugular catheter using the push–pull method at set timepoints up to 48 hours. Sample analysis was performed with high‐performance liquid chromatography. Mean grapiprant plasma concentration was 164.3 ± 104.7 ng/mL which occurred at 0.8 ± 0.3 h. This study demonstrated that grapiprant concentrations consistent with analgesia in dogs were reached at this dosage in pigs. Further studies are needed to evaluate the efficacy of grapiprant in pigs.

Subjects

MeSH terms (MEDLINE)

OsteoarthritisDog DiseasesSwine DiseasesAnimalsDogsSwineSulfonylurea CompoundsPainPain ManagementSus scrofaImidazolesPyridinesBenzenesulfonamides

Author keywords

grapiprantnon-steroidal anti-inflammatory drugpig

Substances

Sulfonylurea CompoundsgrapiprantImidazolesPyridinesBenzenesulfonamides

Authors and institutions

  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.
  • Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.

ORCID profiles: Stephanie Kleine

Funding

  • University of Tennessee, Knoxville

Cite

APA

Kleine, S., Hampton, C. E., Smith, C., Bussieres, G., Mulon, P. Y., Seddighi, R., Cox, S., & Smith, J. (2023). Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs ( Sus scrofa domestica ). Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13402

Vancouver

Kleine S, Hampton CE, Smith C, Bussieres G, Mulon PY, Seddighi R, et al. Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs ( Sus scrofa domestica ). Journal of Veterinary Pharmacology and Therapeutics. 2023. doi:10.1111/jvp.13402

BibTeX
@article{Kleine2023,
  author = {Kleine, Stephanie and Hampton, Chiara E and Smith, Christopher and Bussieres, Genevieve and Mulon, Pierre-Yves and Seddighi, Reza and Cox, Sherry and Smith, Joe},
  title = {Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs ( Sus scrofa domestica )},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2023},
  doi = {10.1111/jvp.13402}
}
Start for free →